Oxidative stress in cardiovascular diseases and obesity: Role of p66Shc and protein kinase C

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  De Marchi, Elena ^a   Baldassari, Federica ^a   Bononi, Angela ^a   Wieckowski, Mariusz R ^b   Pinton, Paolo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT DEFENCE SYSTEM; CARDIO-VASCULAR DISEASE; ENVIRONMENTAL FACTORS; GENETIC INTERACTION; INTRACELLULAR REGULATION; OXIDATIVE DAMAGE; REACTIVE OXYGEN SPECIES; THERAPEUTIC STRATEGY;

DISEASES; ENZYMES; NUTRITION; OXYGEN; PATHOLOGY; PROTEINS;

OXIDATIVE STRESS;

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BILIRUBIN; CAROTENOID; GLUTATHIONE; HYDROGEN PEROXIDE; LYCOPENE; PROTEIN KINASE C; PROTEIN P66; PROTEIN SHC; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; URIC ACID; SHC1 PROTEIN, HUMAN;

ADIPOCYTE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CYTOPATHOLOGY; ENDOPLASMIC RETICULUM; HUMAN; MITOCHONDRION; MOLECULAR PATHOLOGY; NONHUMAN; OBESITY; OXIDATIVE STRESS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; CYTOLOGY; METABOLISM; PATHOLOGY;

ADIPOCYTES; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; HUMANS; OBESITY; OXIDATIVE STRESS; PROTEIN KINASE C; REACTIVE OXYGEN SPECIES; SHC SIGNALING ADAPTOR PROTEINS;

EID: 84876515368     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/564961     Document Type: Review

References (118)

1. Dandona P., Aljada A., Chaudhuri A., Mohanty P., Garg R., Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005 111 11 1448 1454 2-s2.0-15444366991 10.1161/01.CIR.0000158483.13093.9D (Pubitemid 40396812)
2. Haslam D. W., James W. P. T., Obesity. The Lancet 2005 366 9492 1197 1209 2-s2.0-25844457693 10.1016/S0140-6736(05)67483-1 (Pubitemid 41393598)
3. Afanas'ev I., ROS and RNS signaling in heart disorders: could antioxidant treatment be successful? Oxidative Medicine and Cellular Longevity 2011 2011 13 293769 10.1155/2011/293769
4. Bisbal C., Lambert K., Avignon A., Antioxidants and glucose metabolism disorders. Current Opinion in Clinical Nutrition and Metabolic Care 2010 13 4 439 446 2-s2.0-77954348795 10.1097/MCO.0b013e32833a5559
5. Di Lisa F., Kaludercic N., Carpi A., Menabò R., Giorgio M., Mitochondria and vascular pathology. Pharmacological Reports 2009 61 1 123 130 2-s2.0-66949176522
6. Giorgi C., Agnoletto C., Baldini C., Bononi A., Bonora M., Marchi S., Missiroli S., Patergnani S., Poletti F., Rimessi A., Zavan B., Pinton P., Redox control of protein kinase C: cell-and disease-specific aspects. Antioxidants and Redox Signaling 2010 13 7 1051 1085 2-s2.0-77955916237 10.1089/ars.2009.2825
7. Berniakovich I., Trinei M., Stendardo M., Migliaccio E., Minucci S., Bernardi P., Pelicci P. G., Giorgio M., p66Shc-generated oxidative signal promotes fat accumulation. The Journal of Biological Chemistry 2008 283 49 34283 34293 2-s2.0-57749091893 10.1074/jbc.M804362200
8. Francia P., Cosentino F., Schiavoni M., Huang Y., Perna E., Camici G. G., Lüscher T. F., Volpe M., p66Shc protein, oxidative stress, and cardiovascular complications of diabetes: the missing link. Journal of Molecular Medicine 2009 87 9 885 891 2-s2.0-68949209647 10.1007/s00109-009-0499-3
9. Adam-Vizi V., Chinopoulos C., Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends in Pharmacological Sciences 2006 27 12 639 645 2-s2.0-33751072935 10.1016/j.tips.2006.10.005 (Pubitemid 44767940)
10. 2 signaling. Antioxidants and Redox Signaling 2011 14 3 459 468 2-s2.0-78650869592 10.1089/ars.2010.3363
11. Elahi M. M., Kong Y. X., Matata B. M., Oxidative stress as a mediator of cardiovascular disease. Oxidative Medicine and Cellular Longevity 2009 2 5 259 269 2-s2.0-77953415757 10.4161/oxim.2.5.9441
12. Hulsmans M., van Dooren E., Holvoet P., Mitochondrial reactive oxygen species and risk of atherosclerosis. Current Atherosclerosis Reports 2012 14 3 264 276 10.1007/s11883-012-0237-0
13. Wellen K. E., Thompson C. B., Cellular metabolic stress: considering how cells respond to nutrient excess. Molecular Cell 2010 40 2 323 332 2-s2.0-78649391422 10.1016/j.molcel.2010.10.004
14. Gonen T., Walz T., The structure of aquaporins. Quarterly Reviews of Biophysics 2006 39 4 361 396 2-s2.0-33845669996 10.1017/S0033583506004458 (Pubitemid 44950380)
15. Bienert G. P., Møller A. L. B., Kristiansen K. A., Schulz A., Møller I. M., Schjoerring J. K., Jahn T. P., Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. The Journal of Biological Chemistry 2007 282 2 1183 1192 2-s2.0-33847753534 10.1074/jbc.M603761200 (Pubitemid 47076557)
16. Hawkins B. J., Madesh M., Kirkpatrick C. J., Fisher A. B., Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling. Molecular Biology of the Cell 2007 18 6 2002 2012 2-s2.0-34250349160 10.1091/mbc.E06-09-0830 (Pubitemid 46911353)
17. Lee R., Margaritis M., Channon K. M., Antoniades C., Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Current Medicinal Chemistry 2012 19 16 2504 2520 10.2174/092986712800493057
18. Channon K. M., Guzik T. J., Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. Journal of Physiology and Pharmacology 2002 53 4, part 1 515 524 2-s2.0-0036908442 (Pubitemid 36014798)
19. Liao F., Andalibi A., Qiao J. H., Allayee H., Fogelman A. M., Lusis A. J., Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. Journal of Clinical Investigation 1994 94 2 877 884 2-s2.0-0028047925 (Pubitemid 24251023)
20. Rajagopalan S., Meng X. P., Ramasamy S., Harrison D. G., Galis Z. S., Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: implications for atherosclerotic plaque stability. Journal of Clinical Investigation 1996 98 11 2572 2579 2-s2.0-10544246489 (Pubitemid 26415078)
21. Stocker R., Keaney J. F. Jr., Role of oxidative modifications in atherosclerosis. Physiological Reviews 2004 84 4 1381 1478 2-s2.0-4644310560 10.1152/physrev.00047.2003 (Pubitemid 39302636)
22. Violi F., Basili S., Nigro C., Pignatelli P., Role of NADPH oxidase in atherosclerosis. Future Cardiology 2009 5 1 83 92 2-s2.0-66949169956 10.2217/14796678.5.1.83
23. Puddu P., Puddu G. M., Cravero E., Rosati M., Muscari A., The molecular sources of reactive oxygen species in hypertension. Blood Pressure 2008 17 2 70 77 2-s2.0-45949086327 10.1080/08037050802029954 (Pubitemid 351891172)
24. Dale D. C., Boxer L., Liles W. C., The phagocytes: neutrophils and monocytes. Blood 2008 112 4 935 945 2-s2.0-51649127081 10.1182/blood-2007-12- 077917
25. Garg U. C., Hassid A., Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. Journal of Clinical Investigation 1989 83 5 1774 1777 2-s2.0-0024553336 (Pubitemid 19124139)
26. Cave A., Grieve D., Johar S., Zhang M., Shah A. M., NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology. Philosophical Transactions of the Royal Society B 2005 360 1464 2327 2334 2-s2.0-33745236125 10.1098/rstb.2005.1772 (Pubitemid 46682152)
27. Judkins C. P., Diep H., Broughton B. R. S., Mast A. E., Hooker E. U., Miller A. A., Selemidis S., Dusting G. J., Sobey C. G., Drummond G. R., Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE -/- mice. The American Journal of Physiology 2010 298 1 H24 H32 2-s2.0-73549096170 10.1152/ajpheart.00799.2009
28. Shimizu H., Nakagawa Y., Murakami C., Aoki N., Kim-Mitsuyama S., Miyazaki H., Protein tyrosine phosphatase PTP ε M negatively regulates PDGF β -receptor signaling induced by high glucose and PDGF in vascular smooth muscle cells. The American Journal of Physiology 2010 299 5 C1144 C1152 2-s2.0-78349257749 10.1152/ajpcell.00536.2009
29. Kuroda J., Ago T., Matsushima S., Zhai P., Schneider M. D., Sadoshima J., NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proceedings of the National Academy of Sciences of the United States of America 2010 107 35 15565 15570 2-s2.0-77957272433 10.1073/pnas.1002178107
30. Li Y., Huang T. T., Carlson E. J., Melov S., Ursell P. C., Olson J. L., Noble L. J., Yoshimura M. P., Berger C., Chan P. H., Wallace D. C., Epstein C. J., Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genetics 1995 11 4 376 381 2-s2.0-0028827252
31. Armani C., Landini L. Jr., Leone A., Molecular and biochemical changes of the cardiovascular system due to smoking exposure. Current Pharmaceutical Design 2009 15 10 1038 1053 2-s2.0-65649140077 10.2174/138161209787846973
32. Amaral S., Oliveira P. J., Ramalho-Santos J., Diabetes and the impairment of reproductive function: possible role of mitochondria and reactive oxygen species. Current Diabetes Reviews 2008 4 1 46 54 2-s2.0-38949101210 10.2174/157339908783502398 (Pubitemid 351210972)
33. Puddu P., Puddu G. M., Cravero E., de Pascalis S., Muscari A., The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis. Journal of Biomedical Science 2009 16 article 112 2-s2.0-76249124669 10.1186/1423-0127-16-112
34. Giunta S., Jackson S. P., Give me a break, but not in mitosis: the mitotic DNA damage response marks DNA double strand breaks with early signaling events. Cell Cycle 2011 10 8 1215 1221 2-s2.0-79954527572 10.4161/cc.10.8.15334
35. Yu E., Mercer J., Bennett M., Mitochondria in vascular disease. Cardiovascular Research 2012 95 2 173 182 10.1093/cvr/cvs111
36. Martin-Padura I., de Nigris F., Migliaccio E., Mansueto G., Minardi S., Rienzo M., Lerman L., Stendardo M., Giorgio M., de Rosa G., Pelicci P. G., Napoli C., p66Shc deletion confers vascular protection in advanced atherosclerosi in hypercholesterolemic apolipoprotein E knockout mice. Endothelium 2008 15 5-6 276 287 2-s2.0-60549112093 10.1080/10623320802487791
37. Rota M., LeCapitaine N., Hosoda T., Boni A., de Angelis A., Padin-Iruegas M. E., Esposito G., Vitale S., Urbanek K., Casarsa C., Giorgio M., Lüscher T. F., Pelicci P. G., Anversa P., Leri A., Kajstura J., Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circulation Research 2006 99 1 42 52 2-s2.0-33746207801 10.1161/01.RES.0000231289.63468.08 (Pubitemid 44297054)
38. Lebiedzinska M., Duszynski J., Rizzuto R., Pinton P., Wieckowski M. R., Age-related changes in levels of p66Shc and serine 36-phosphorylated p66Shc in organs and mouse tissues. Archives of Biochemistry and Biophysics 2009 486 1 73 80 2-s2.0-67349112394 10.1016/j.abb.2009.03.007
39. Marchi S., Giorgi C., Suski J. M., Agnoletto C., Bononi A., Bonora M., de Marchi E., Missiroli S., Patergnani S., Poletti F., Mitochondria-Ros crosstalk in the control of cell death and aging. Journal of Signal Transduction 2012 2012 17 329635 10.1155/2012/329635
40. Luzi L., Confalonieri S., Di Fiore P. P., Pelicci P. G., Evolution of Shc functions from nematode to human. Current Opinion in Genetics and Development 2000 10 6 668 674 2-s2.0-0033669885 10.1016/S0959-437X(00)00146-5
41. Pelicci G., Lanfrancone L., Grignani F., McGlade J., Cavallo F., Forni G., Nicoletti I., Grignani F., Pawson T., Pelicci P. G., A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 1992 70 1 93 104 2-s2.0-0026777369 10.1016/0092-8674(92)90536-L
42. Migliaccio E., Mele S., Salcini A. E., Pelicci G., Lai K. M. V., Superti-Furga G., Pawson T., Di Fiore P. P., Lanfrancone L., Pelicci P. G., Opposite effects of the p52(shc)/p46(shc) and p66(shc) splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. The EMBO Journal 1997 16 4 706 716 2-s2.0-0031056755 10.1093/emboj/16.4.706 (Pubitemid 27089518)
43. Nemoto S., Finkel T., Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 2002 295 5564 2450 2452 2-s2.0-0037192473 10.1126/science.1069004 (Pubitemid 34270258)
44. Pinton P., Rimessi A., Marchi S., Orsini F., Migliaccio E., Giorgio M., Contursi C., Minucci S., Mantovani F., Wieckowski M. R., Del Sal G., Pelicci P. G., Rizzuto R., Protein kinase C β and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 2007 315 5812 659 663 2-s2.0-33846817351 10.1126/science.1135380 (Pubitemid 46214712)
45. Trinei M., Berniakovich I., Beltrami E., Migliaccio E., Fassina A., Pelicci P., Giorgio M., P66Shc signals to age. Aging 2009 1 6 503 510 2-s2.0-77953953488
46. Pinton P., Rizzuto R., p66Shc, oxidative stress and aging: importing a lifespan determinant into mitochondria. Cell Cycle 2008 7 3 304 308 2-s2.0-40549146557 (Pubitemid 351366492)
47. Rimessi A., Rizzuto R., Pinton P., Differential recruitment of PKC isoforms in HeLa cells during redox stress. Cell Stress and Chaperones 2007 12 4 291 298 2-s2.0-40749152802 10.1379/CSC-211.1
48. Suski J. M., Karkucinska-Wieckowska A., Lebiedzinska M., Giorgi C., Szczepanowska J., Szabadkai G., Duszynski J., Pronicki M., Pinton P., Wieckowski M. R., p66Shc aging protein in control of fibroblasts cell fate. International Journal of Molecular Sciences 2011 12 8 5373 5389 10.3390/ijms12085373
49. Migliaccio E., Giogio M., Mele S., Pelicci G., Reboldi P., Pandolfi P. P., Lanfrancone L., Pelicci P. G., The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999 402 6759 309 313 2-s2.0-0033581704 10.1038/46311 (Pubitemid 129516269)
50. Giorgio M., Berry A., Berniakovich I., Poletaeva I., Trinei M., Stendardo M., Hagopian K., Ramsey J. J., Cortopassi G., Migliaccio E., The p66Shc knocked out mice are short lived under natural condition. Aging Cell 2012 11 1 162 168 10.1111/j.1474-9726.2011.00770.x
51. Napoli C., Martin-Padura I., de Nigris F., Giorgio M., Mansueto G., Somma P., Condorelli M., Sica G., de Rosa G., Pelicci P. G., Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proceedings of the National Academy of Sciences of the United States of America 2003 100 4 2112 2116 2-s2.0-0037452461 10.1073/pnas.0336359100 (Pubitemid 36254582)
52. Camici G. G., Schiavoni M., Francia P., Bachschmid M., Martin-Padura I., Hersberger M., Tanner F. C., Pelicci P., Volpe M., Anversa P., Lüscher T. F., Cosentino F., Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proceedings of the National Academy of Sciences of the United States of America 2007 104 12 5217 5222 2-s2.0-34247596394 10.1073/pnas.0609656104 (Pubitemid 47186202)
53. Shi Y., Cosentino F., Camici G. G., Akhmedov A., Vanhoutte P. M., Tanner F. C., Luscher T. F., Oxidized low-density lipoprotein activates p66Shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase C- β and c-Jun N-terminal kinase kinase in human endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 9 2090 2097 10.1161/ATVBAHA.111.229260
54. Cosentino F., Francia P., Camici G. G., Pelicci P. G., Lüscher T. F., Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 4 622 628 2-s2.0-42249097446 10.1161/ATVBAHA.107.156059 (Pubitemid 351651330)
55. Carpi A., Menabò R., Kaludercic N., Pelicci P., Di Lisa F., Giorgio M., The cardioprotective effects elicited by p66Shc ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury. Biochimica et Biophysica Acta 2009 1787 7 774 780 2-s2.0-67649243697 10.1016/j.bbabio.2009.04.001
56. Noda Y., Yamagishi S. I., Matsui T., Ueda S., Ueda S. I., Jinnouchi Y., Hirai Y., Imaizumi T., The p66shc gene expression in peripheral blood monocytes is increased in patients with coronary artery disease. Clinical Cardiology 2010 33 9 548 552 2-s2.0-77956909543 10.1002/clc.20761
57. Yang X. M., Sato H., Downey J. M., Cohen M. V., Protection of ischemic preconditioning is dependent upon a critical timing sequence of protein kinase C activation. Journal of Molecular and Cellular Cardiology 1997 29 3 991 999 2-s2.0-0031105023 10.1006/jmcc.1996.0344 (Pubitemid 27196526)
58. Dorn G. W. II, Souroujon M. C., Liron T., Chen C. H., Gray M. O., Zhou H. Z., Csukai M., Wu G., Lorenz J. N., Mochly-Rosen D., Sustained in vivo cardiac protection by a rationally designed peptide that causes ε protein kinase C translocation. Proceedings of the National Academy of Sciences of the United States of America 1999 96 22 12798 12803 2-s2.0-13044274187 10.1073/pnas.96.22. 12798 (Pubitemid 29513582)
59. Chen L., Hahn H., Wu G., Chen C. H., Liron T., Schechtman D., Cavallaro G., Banci L., Guo Y., Bolli R., Dorn G. W., Mochly-Rosen D., Opposing cardioprotective actions and parallel hypertrophic effects of δ PKC and ε PKC. Proceedings of the National Academy of Sciences of the United States of America 2001 98 20 11114 11119 2-s2.0-0035949580 10.1073/pnas.191369098 (Pubitemid 32928691)
60. Leitges M., Mayr M., Braun U., Mayr U., Li C., Pfister G., Ghaffari-Tabrizi N., Baier G., Hu Y., Xu Q., Exacerbated vein graft arteriosclerosis in protein kinase C δ -null mice. Journal of Clinical Investigation 2001 108 10 1505 1512 2-s2.0-0035179086 10.1172/JCI200112902 (Pubitemid 33091988)
61. Jaimes E. A., Galceran J. M., Raij L., Angiotensin II induces superoxide anion production by mesangial cells. Kidney International 1998 54 3 775 784 2-s2.0-0031708389 10.1046/j.1523-1755.1998.00068.x (Pubitemid 28397395)
62. Sonta T., Inoguchi T., Matsumoto S., Yasukawa K., Inuo M., Tsubouchi H., Sonoda N., Kobayashi K., Utsumi H., Nawata H., In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker. Biochemical and Biophysical Research Communications 2005 330 2 415 422 2-s2.0-20144376707 10.1016/j.bbrc.2005.02.174 (Pubitemid 40417661)
63. Sasaki S., Inoguchi T., The role of oxidative stress in the pathogenesis of diabetic vascular complications. Diabetes and Metabolism Journal 2012 36 4 255 261 10.4093/dmj.2012.36.4.255
64. Spiegelman B. M., Flier J. S., Obesity and the regulation of energy balance. Cell 2001 104 4 531 543 2-s2.0-0035936764 10.1016/S0092-8674(01)00240-9 (Pubitemid 32201948)
65. Pihl E., Zilmer K., Kullisaar T., Kairane C., Mägi A., Zilmer M., Atherogenic inflammatory and oxidative stress markers in relation to overweight values in male former athletes. International Journal of Obesity 2006 30 1 141 146 2-s2.0-29044447177 10.1038/sj.ijo.0803068 (Pubitemid 41790790)
66. Chrysohoou C., Panagiotakos D. B., Pitsavos C., Skoumas I., Papademetriou L., Economou M., Stefanadis C., The implication of obesity on total antioxidant capacity in apparently healthy men and women: the ATTICA study. Nutrition, Metabolism and Cardiovascular Diseases 2007 17 8 590 597 2-s2.0-34548124619 10.1016/j.numecd.2006.05.007 (Pubitemid 47302303)
67. Avignon A., Hokayem M., Bisbal C., Lambert K., Dietary antioxidants: do they have a role to play in the ongoing fight against abnormal glucose metabolism? Nutrition 2012 28 7-8 715 721 10.1016/j.nut.2012.01.001
68. Tripathy D., Mohanty P., Dhindsa S., Syed T., Ghanim H., Aliada A., Dandona P., Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 2003 52 12 2882 2887 2-s2.0-0345275811 10.2337/diabetes.52.12.2882 (Pubitemid 37466856)
69. Yip J., Facchini F. S., Reaven G. M., Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 1998 83 8 2773 2776 2-s2.0-0031726145 10.1210/jc.83.8.2773 (Pubitemid 28493774)
70. Du X., Edelstein D., Obici S., Higham N., Zou M. H., Brownlee M., Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. Journal of Clinical Investigation 2006 116 4 1071 1080 2-s2.0-33645509709 10.1172/JCI23354
71. Cho S. J., Roman G., Yeboah F., Konishi Y., The road to advanced glycation end products: a mechanistic perspective. Current Medicinal Chemistry 2007 14 15 1653 1671 2-s2.0-34347327190 10.2174/092986707780830989 (Pubitemid 47010154)
72. Piperi C., Adamopoulos C., Dalagiorgou G., Diamanti-Kandarakis E., Papavassiliou A. G., Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases. Journal of Clinical Endocrinology and Metabolism 2012 97 7 2231 2242 10.1210/jc.2011-3408
73. Sims T. J., Rasmussen L. M., Oxlund H., Bailey A. J., The role of glycation cross-links in diabetic vascular stiffening. Diabetologia 1996 39 8 946 951 2-s2.0-0029893422 10.1007/s001250050536 (Pubitemid 26249114)
74. Bucala R., Makita Z., Vega G., Grundy S., Koschinsky T., Cerami A., Vlassara H., Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proceedings of the National Academy of Sciences of the United States of America 1994 91 20 9441 9445 2-s2.0-0027956982 (Pubitemid 24297930)
75. Zieman S., Kass D., Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease. Congestive Heart Failure 2004 10 3 144 151 2-s2.0-4344632810
76. Tessier F. J., The Maillard reaction in the human body. The main discoveries and factors that affect glycation. Pathologie Biologie 2010 58 3 214 219 2-s2.0-77953621114 10.1016/j.patbio.2009.09.014
77. Luevano-Contreras C., Chapman-Novakofski K., Dietary advanced glycation end products and aging. Nutrients 2010 2 12 1247 1265 2-s2.0-79952067125 10.3390/nu2121247
78. Vazzana N., Guagnano M. T., Cuccurullo C., Ferrante E., Lattanzio S., Liani R., Romano M., Davi G., Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress. Journal of Clinical Endocrinology and Metabolism 2012 97 9 1726 1730 10.1210/jc.2012-1473
79. Jiao P., Ma J., Feng B., Zhang H., Diehl J. A., Chin Y. E., Yan W., Xu H., FFA-induced adipocyte inflammation and insulin resistance: involvement of ER stress and IKK β pathways. Obesity 2011 19 3 483 491 2-s2.0-79952003715 10.1038/oby.2010.200
80. Özcan U., Cao Q., Yilmaz E., Lee A. H., Iwakoshi N. N., Özdelen E., Tuncman G., Görgün C., Glimcher L. H., Hotamisligil G. S., Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004 306 5695 457 461 2-s2.0-5644231992 10.1126/science.1103160 (Pubitemid 39372439)
81. Kawasaki N., Asada R., Saito A., Kanemoto S., Imaizumi K., Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue. Scientific Reports 2012 2 article 799 10.1038/srep00799
82. Alfadda A. A., Sallam R. M., Reactive oxygen species in health and disease. Journal of Biomedicine and Biotechnology 2012 2012 14 936486 10.1155/2012/936486
83. Calle E. E., Kaaks R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews Cancer 2004 4 8 579 591 2-s2.0-3543072186 (Pubitemid 39025053)
84. Renehan A. G., Tyson M., Egger M., Heller R. F., Zwahlen M., Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The Lancet 2008 371 9612 569 578 2-s2.0-38949108241 10.1016/S0140-6736(08)60269-X (Pubitemid 351232031)
85. Robertson A. P., Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet β cells in diabetes. The Journal of Biological Chemistry 2004 279 41 42351 42354 2-s2.0-5644248079 10.1074/jbc.R400019200 (Pubitemid 39372114)
86. Aguiari P., Leo S., Zavan B., Vindigni V., Rimessi A., Bianchi K., Franzin C., Cortivo R., Rossato M., Vettor R., Abatangelo G., Pozzan T., Pinton P., Rizzuto R., High glucose induces adipogenic differentiation of muscle-derived stem cells. Proceedings of the National Academy of Sciences of the United States of America 2008 105 4 1226 1231 2-s2.0-39549121054 10.1073/pnas.0711402105 (Pubitemid 351397035)
87. Nishikawa T., Edelstein D., Du X. L., Yamagishi S. I., Matsumura T., Kaneda Y., Yorek M. A., Beebe D., Oates P. J., Hammes H. P., Glardino I., Brownlee M., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000 404 6779 787 790 2-s2.0-0034643340 10.1038/35008121 (Pubitemid 30212409)
88. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. Journal of Clinical Investigation 2009 119 3 573 581 2-s2.0-67650815430 10.1172/JCI37048
89. Lee H., Lee Y. J., Choi H., Ko E. H., Kim J. W., Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. The Journal of Biological Chemistry 2009 284 16 10601 10609 2-s2.0-67449091887 10.1074/jbc.M808742200
90. Park H. S., Kim S. H., Kim Y. S., Ryu S. Y., Hwang J. T., Yang H. J., Kim G. H., Kwon D. Y., Kim M. S., Luteolin inhibits adipogenic differentiation by regulating PPARc activation. BioFactors 2009 35 4 373 379 2-s2.0-70449711110 10.1002/biof.38
91. Calzadilla P., Sapochnik D., Cosentino S., Diz V., Dicelio L., Calvo J. C., Guerra L. N., N-acetylcysteine reduces markers of differentiation in 3T3-L1 adipocytes. International Journal of Molecular Sciences 2011 12 10 6936 6951 10.3390/ijms12106936
92. Kim J. R., Ryu H. H., Chung H. J., Lee J. H., Kim S. W., Kwun W. H., Baek S. H., Kim J. H., Association of anti-obesity activity of N-acetylcysteine with metallothionein-II down-regulation. Experimental and Molecular Medicine 2006 38 2 162 172 2-s2.0-33646764163
93. Carpéné C., Iffiú-Soltesz Z., Bour S., Prévot D., Valet P., Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats. Pharmacological Research 2007 56 6 522 530 2-s2.0-36348999936 10.1016/j.phrs.2007.09.016 (Pubitemid 350148166)
94. Itani S. I., Zhou Q., Pories W. J., MacDonald K. G., Dohm G. L., Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes 2000 49 8 1353 1358 2-s2.0-0033861608 (Pubitemid 30624237)
95. Schmitz-Peiffer C., Protein kinase C and lipid-induced insulin resistance in skeletal muscle. Annals of the New York Academy of Sciences 2002 967 146 157 2-s2.0-0036295566 (Pubitemid 34721902)
96. Fleming S., Mackenzie J., Vemon R. G., Anderson N. G., Houslay M. D., Kilgour E., Protein kinase C isoforms play differential roles in the regulation of adipocyte differentiation. Biochemical Journal 1998 333 part 3 719 727 (Pubitemid 28398541)
97. Bansode R. R., Huang W., Roy S. K., Mehta M., Mehta K. D., Protein kinase C β deficiency increases fatty acid oxidation and reduces fat storage. The Journal of Biological Chemistry 2008 283 1 231 236 2-s2.0-38049134621 10.1074/jbc.M707268200
98. Huang W., Bansode R., Mehta M., Mehta K. D., Loss of protein kinase C β function protects mice again diet-induced obesity and development of hepatic steatosis and insulin resistance. Hepatology 2009 49 5 1525 1536 2-s2.0-66149093022 10.1002/hep.22815
99. Gálvez M. I. L., Protein Kinase C inhibitors in the treatment of diabetic retinopathy. Review. Current Pharmaceutical Biotechnology 2011 12 3 386 391 2-s2.0-79551678495 10.2174/138920111794480606
100. Pavan C., Vindigni V., Michelotto L., Rimessi A., Abatangelo G., Cortivo R., Pinton P., Zavan B., Weight gain related to treatment with atypical antipsychotics is due to activation of PKC- β Pharmacogenomics Journal 2010 10 5 408 417 2-s2.0-77957113550 10.1038/tpj.2009.67
101. Gebhardt S., Haberhausen M., Heinzel-Gutenbrunner M., Gebhardt N., Remschmidt H., Krieg J. C., Hebebrand J., Theisen F. M., Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course. Journal of Psychiatric Research 2009 43 6 620 626 2-s2.0-60949099657 10.1016/j.jpsychires.2008.11.001
102. Raffaello A., Rizzuto R., Mitochondrial longevity pathways. Biochimica et Biophysica Acta 2011 1813 1 260 268 2-s2.0-78650736695 10.1016/j.bbamcr.2010. 10.007
103. Ranieri S. C., Fusco S., Panieri E., Labate V., Mele M., Tesori V., Ferrara A. M., Maulucci G., de Spirito M., Martorana G. E., Galeotti T., Pani G., Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2010 107 30 13420 13425 2-s2.0-77955798757 10.1073/pnas.1008647107
104. Tomilov A. A., Ramsey J. J., Hagopian K., Giorgio M., Kim K. M., Lam A., Migliaccio E., Lloyd K. C., Berniakovich I., Prolla T. A., Pelicci P., Cortopassi G. A., The Shc locus regulates insulin signaling and adiposity in mammals. Aging Cell 2011 10 1 55 65 2-s2.0-78651344799 10.1111/j.1474-9726.2010. 00641.x
105. Montezano A. C., Touyz R. M., Molecular mechanisms of hypertension-reactive oxygen species and antioxidants: a basic science update for the clinician. Canadian Journal of Cardiology 2012 28 3 288 295 10.1016/j.cjca.2012.01.017
106. Gongora M. C., Qin Z., Laude K., Kim H. W., McCann L., Folz J. R., Dikalov S., Fukai T., Harrison D. G., Role of extracellular superoxide dismutase in hypertension. Hypertension 2006 48 3 473 481 2-s2.0-33747404190 10.1161/01.HYP.0000235682.47673.ab (Pubitemid 44253743)
107. Traber M. G., Stevens J. F., Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radical Biology and Medicine 2011 51 5 1000 1013 10.1016/j.freeradbiomed.2011.05.017
108. Rimm E. B., Stampfer M. J., Antioxidants for vascular disease. Medical Clinics of North America 2000 84 1 239 249 2-s2.0-0033979504 (Pubitemid 30068901)
109. Lane J. S., Magno C. P., Lane K. T., Chan T., Hoyt D. B., Greenfield S., Nutrition impacts the prevalence of peripheral arterial disease in the United States. Journal of Vascular Surgery 2008 48 4 897.e1 904.e1 2-s2.0-55149117086 10.1016/j.jvs.2008.05.014
110. Barsacchi R., Coassin M., Maiorino M., Pelosi G., Simonelli C., Ursini F., Increased ultra weak chemiluminescence emission from rat heart at postischemic reoxygenation: protective role of vitamin E. Free Radical Biology and Medicine 1989 6 6 573 579 2-s2.0-0024308199 (Pubitemid 19147806)
111. Janero D. R., Burghardt B., Oxidative injury to myocardial membrane: direct modulation by endogenous α -tocopherol. Journal of Molecular and Cellular Cardiology 1989 21 11 1111 1124 2-s2.0-0024849696 10.1016/0022-2828(89) 90689-5 (Pubitemid 20028823)
112. Klein H. H., Pich S., Lindert-Heimberg S., Nebendahl K., Niedmann P., Failure of chronic, high-dose, oral vitamin E treatment to protect the ischemic, reperfused porcine heart. Journal of Molecular and Cellular Cardiology 1993 25 1 103 112 2-s2.0-0027514752 10.1006/jmcc.1993.1011 (Pubitemid 23053319)
113. Haramaki N., Packer L., Assadnazari H., Zimmer G., Cardiac recovery during post-ischemic reperfusion is improved by combination of vitamin E with dihydrolipoic acid. Biochemical and Biophysical Research Communications 1993 196 3 1101 1107 2-s2.0-0027453335 10.1006/bbrc.1993.2364 (Pubitemid 23347561)
114. Rotenberg S. A., Krauss R. S., Borner C. M. B., Weinstein I. B., Characterization of a specific form of protein kinase C overproduced by a C3H 10T(1/2) cell line. Biochemical Journal 1990 266 1 173 178 2-s2.0-0025057643 (Pubitemid 20069036)
115. Riccioni G., Speranza L., Pesce M., Cusenza S., D'Orazio N., Glade M. J., Novel phytonutrient contributors to antioxidant protection against cardiovascular disease. Nutrition 2012 28 6 605 610 10.1016/j.nut.2011.11.028
116. Sari I., Baltaci Y., Bagci C., Davutoglu V., Erel O., Celik H., Ozer O., Aksoy N., Aksoy M., Effect of pistachio diet on lipid parameters, endothelial function, inflammation, and oxidative status: a prospective study. Nutrition 2010 26 4 399 404 2-s2.0-77349114681 10.1016/j.nut.2009.05.023
117. Hutley L., Prins J. B., Fat as an endocrine organ: relationship to the metabolic syndrome. American Journal of the Medical Sciences 2005 330 6 280 289 2-s2.0-29244465117 (Pubitemid 41831898)
118. Guzik T. J., Mangalat D., Korbut R., Adipocytokines-novel link between inflammation and vascular function? Journal of Physiology and Pharmacology 2006 57 4 505 528 2-s2.0-33846263404 (Pubitemid 46096102)